Abstract:OBJECTIVE:To study the expression of ephrin-A7 (EphA7) and metadherin (MTDH) and their clinicopathological significances in the benign and malignant lesions of gallbladder.METHODS:EnVisiom immunohistochemical methods was used for determining the expressions of EphA7 and MTDH in routinely paraffin-embedded sections of surgically-resected specimens from 108 cases with gallbladder adenocarcinoma, 15 cases with adenomatous polyp and 35 cases with chronic cholecystitis treated from June 1996 to June 2006. And 46 cases of peritumoral tissues were also harvested as controls (n = 35).RESULTS:The positive expression rates of EphA7 and MTDH were significantly higher in gallbladder adenocarcinoma than those in peritumoral tissues (χ(2)(EphA7) = 12.65, χ(2)(MTDH) = 13.00; P < 0.01), adenomatous polyp (χ(2)(EphA7) = 8.21, χ(2)(MTDH) = 9.39; P < 0.01) and chronic cholecystitis (χ(2)(EphA7) = 21.21, χ(2)(MTDH) = 23.68; P < 0.01); Moderately-or severely-atypical hyperplasia of gallbladder epithelium was found in the benign lesions with positive expression of EphA7 and/or MTDH. The positive rates of EphA7 and MTDH were significantly lower in the cases of well-differentiated adenocarcinoma, maximal diameter of tumor < 2 cm, no-metastasis of lymph node, and tumor with no-invasiveness of regional tissues than those in the poorly-differentiated adenocarcinoma (χ(2)(EphA7) = 12.34, χ(2)(MTDH) = 12.80; P < 0.01), maximal diameter of tumor ≥ 2 cm (χ(2)(EphA7) = 5.22, χ(2)(MTDH) = 5.00; P < 0.05), cases with metastasis of lymph node (χ(2)(EphA7) = 5.15, χ(2)(MTDH) = 5.86; P < 0.05) and cases with invasiveness of regional tissues (χ(2)(EphA7) = 7.06, P < 0.01; χ(2)(MTDH) = 4.13; P < 0.05) in gallbladder adenocarcinoma (P < 0.05). The high consistency was found between the expressive levels of EphA7 and MTDH in gallbladder adenocarcinoma (χ(2) = 13.11, P < 0.01). The univariate Kaplan-Meier analysis showed that the increased expression of EphA7 (P = 0.023) and MTDH (P = 0.034) was negatively associated with the overall survival. The multivariate Cox regression analysis showed that increased expression of EphA7 and/or MTDH (P(EphA2) = 0.023, P(MTDH) = 0.034) was an independent poor-prognostic predictor for gallbladder adenocarcinoma.CONCLUSIONS:The expression of EphA7 and/or MTDH might be closely related to the carcinogenesis, progression, clinical biological behaviors and prognosis of gallbladder adenocarcinoma. The positive expression of EphA7 and/or MTDH may predict bad-prognosis in gallbladder adenocarcinoma.

Expression of eadual type homobox transcription factor-2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its clinicopathological significance

Expression of Cdx2 and Hepatocyte Antigen in Benign and Malignant Lesions of Gallbladder and Its Correlation with Histopathologic Type and Clinical Outcome

The Expression of E-cadherin, Α- or Β-Catenin in Gallbladder Carcinoma and Cholangiocarcinoma and Implication

Expression and clinical significance of GS,E-cadherin and β-catenin in hepatocellular carcinoma

[Expression of Enhancer of Zesle Homolog 2 and Phosphatase and Tension Homolog and Its Clinicopathological Significance in Benign and Malignant Lesion of Gallbladder].

Expression of S-phase kinase associated protein 2 (Skp2) and E2F1 in benign and malignant lesions of gallbladder and its clinicopathological significance

Expressions of carbohydrate CA72.4 and CA242 and clinicopathological significance in benign and malignant lesions of gallbladder

Expression of HMGA2 and CD9 and Their Clinicopathological Significances in Benign and Malignant Lesions of Gallbladder

Expression Levels of HMGA2 and CD9 and Its Clinicopathological Significances in the Benign and Malignant Lesions of the Gallbladder

Expression of CCL3 and its receptor CCR1 in gallbladder adenocarcinoma and its benign lesions and its clinico-pathological significance

Expression of HMGA2 and CD9 in Chronic Liver Disease and Primary Hepatocellular Carcino-ma and Its Significance

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

[Expression of Ephrin-A7 and Metadherin and Its Clinicopathological Significances in the Benign and Malignant Lesions of Gallbladder].

Expression of dysadherin and its significance in primary hepatocellular carcinomas

Expression of homeodomain protein CDX2 in gallbladder carcinomas

Expression of ABCG2, SFRP2, BRMS1 and HPA in Benign and Malignant Lesions of the Gallbladder and Their Clinicopathological Significances

Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder.

[Expression of annexin A1 (ANXA1) and A2 (ANXA2) and its significance in benign and malignant lesions of gallbladder].

Relationship of CDX-2 with Intestinal Metaplasia and Biliary Tract Tumor

Expression of Cdx2 and Hepatocyte Antigen in Gastric Carcinoma: Correlation with Histologic Type and Implications for Prognosis

Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression of Gallbladder Adenocarcinoma.